Your browser doesn't support javascript.
loading
Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy.
Esteban, Emilio; Exposito, Francisco; Crespo, Guillermo; Lambea, Julio; Pinto, Alvaro; Puente, Javier; Arranz, Jose A; Redrado, Miriam; Rodriguez-Antona, Cristina; de Andrea, Carlos; Lopez-Brea, Marta; Redin, Esther; Rodriguez, Angel; Serrano, Diego; Garcia, Jorge; Grande, Enrique; Castellano, Daniel; Calvo, Alfonso.
Afiliação
  • Esteban E; Medical Oncology Department, Hospital Central de Asturias, 33011 Oviedo, Spain.
  • Exposito F; IDISNA and Program in Solid Tumors, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
  • Crespo G; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
  • Lambea J; CIBERONC, Instituto de Salud Carlos III (ISCIII), 28020 Madrid, Spain.
  • Pinto A; Medical Oncology Department, Burgos University Hospital, 09006 Burgos, Spain.
  • Puente J; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.
  • Arranz JA; Medical Oncology Department, University Hospital La Paz, IdiPAZ, 28046 Madrid, Spain.
  • Redrado M; Medical Oncology Department, San Carlos Hospital, IdISSC, 28040 Madrid, Spain.
  • Rodriguez-Antona C; Medical Oncology Department, University Hospital Gregorio Marañón, 28009 Madrid, Spain.
  • de Andrea C; IDISNA and Program in Solid Tumors, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
  • Lopez-Brea M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain.
  • Redin E; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
  • Rodriguez A; Department of Pathology, University Clinic of Navarra, 31009 Pamplona, Spain.
  • Serrano D; Medical Oncology Department, Marqués de Valdecilla Hospital, 39008 Santander, Spain.
  • Garcia J; IDISNA and Program in Solid Tumors, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
  • Grande E; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
  • Castellano D; CIBERONC, Instituto de Salud Carlos III (ISCIII), 28020 Madrid, Spain.
  • Calvo A; Medical Oncology Department, León Hospital, 24008 León, Spain.
Cancers (Basel) ; 13(11)2021 Jun 07.
Article em En | MEDLINE | ID: mdl-34200459
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha